Renal safety of tenofovir in HIV treatment-experienced patients

被引:146
作者
Izzedine, H [1 ]
Isnard-Bagnis, C
Hulot, JS
Vittecoq, D
Cheng, A
Jais, CK
Launay-Vacher, V
Deray, G
机构
[1] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Clin Pharmacol, Paris, France
[3] Kremlin Bicetre Hosp, Dept Infect Dis, Paris, France
[4] Gilead Sci Inc, Foster City, CA 94404 USA
[5] AFSSAPS, French Hlth Prod Safety Agcy, St Denis, France
关键词
D O I
10.1097/00002030-200404300-00019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The safety of tenofovir disoproxil fumarate (TDF) was assessed in two double-blind, placebo-controlled studies. Furthermore, we retrospectively collected 19 cases of TDF-associated tubular dysfunction. The incidence of renal events was similar among the active TDF groups and the placebo group in the two double-blind, placebo-controlled studies. Proximal tubulopathy was diagnosed 6.89 +/- 5.51 months after TDF therapy started. All abnormalities normalized within 4.7 +/- 2.94 weeks after drug discontinuation.
引用
收藏
页码:1074 / 1076
页数:3
相关论文
共 11 条
[1]  
BLICK G, 2003, 10 C RETR OPP INF BO
[2]   PATTERN OF GLOMERULAR INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - AN ITALIAN STUDY [J].
CASANOVA, S ;
MAZZUCCO, G ;
DIBELGIOJOSO, GB ;
MOTTA, M ;
BOLDORINI, R ;
GENDERINI, A ;
MONGA, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (03) :446-453
[3]   Rapid communication: Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity [J].
Coca, S ;
Perazella, MA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (06) :342-344
[4]   Renal lesions in HIV-1-positive patient treated with tenofovir [J].
Créput, C ;
Gonzalez-Canali, G ;
Hill, G ;
Piketty, C ;
Kazatchkine, M ;
Nochy, D .
AIDS, 2003, 17 (06) :935-937
[5]   Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women [J].
Gardner, LI ;
Holmberg, SD ;
Williamson, JM ;
Szczech, LA ;
Carpenter, CCJ ;
Rompalo, AM ;
Schuman, P ;
Klein, RS .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (02) :203-209
[6]  
ISNARDBAGNIS C, 2002, J AM SOC NEPHROL, V13, pA448
[7]   HIV-ASSOCIATED IMMUNE-MEDIATED RENAL-DISEASE [J].
KIMMEL, PL ;
PHILLIPS, TM ;
FERREIRACENTENO, A ;
FARKASSZALLASI, T ;
ABRAHAM, AA ;
GARRETT, CT .
KIDNEY INTERNATIONAL, 1993, 44 (06) :1327-1340
[8]   ELECTROLYTE AND ACID-BASE-DISORDERS ASSOCIATED WITH AIDS - AN ETIOLOGIC REVIEW [J].
PERAZELLA, MA ;
BROWN, E .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1994, 9 (04) :232-236
[9]  
Reynes J., 2003, 10 C RETR OPP INF BO
[10]   Predictors of proteinuria and renal failure among women with HIV infection [J].
Szczech, LA ;
Gange, SJ ;
van der Horst, C ;
Bartlett, JA ;
Young, M ;
Cohen, MH ;
Anastos, K ;
Klassen, PS ;
Svetkey, LP .
KIDNEY INTERNATIONAL, 2002, 61 (01) :195-202